Children with multiple sclerosis (MS) who have more paramagnetic rim lesions (PRLs) — areas of chronic active inflammation seen on MRI scans — tend to lose more brain volume over time, a new study found. These lesions were common in pediatric MS, a rare form of the disease…
Read more
I wrote in the summer about changing the disease-modifying therapy (DMT) for my multiple sclerosis (MS). I’ve familiarized myself with the available DMTs, and I plan to ask my neurologist for her recommendation next week and then make a decision. As I’ve researched my options, I’ve become interested…
Recognized each year in March, Multiple Sclerosis Awareness Month is an annual effort to expand public awareness of MS, support the MS community, and highlight the lived experiences of people living with MS. Established in 2003, the month promotes education, advocacy, and fundraising that…
To call my medical career a series of random pivots is an understatement. I have multiple sclerosis (MS) to thank for this wandering journey, one with an uncertain destination, but a surprisingly meaningful landing place. Anesthesiology was my first love. I adored tinkering with the anesthesia machine, working with…
Specific disease-modifying therapies (DMTs) significantly slow the rate of brain volume loss in adults with multiple sclerosis (MS), a benefit that is directly linked to reduced long-term disability, according to a new review. A network meta-analysis of more than 26,000 patients confirms that therapies most effective at preserving…
Get regular updates to your inbox.
